1. Home
  2. LIPO vs SVRE Comparison

LIPO vs SVRE Comparison

Compare LIPO & SVRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIPO
  • SVRE
  • Stock Information
  • Founded
  • LIPO 2005
  • SVRE 2014
  • Country
  • LIPO United States
  • SVRE Israel
  • Employees
  • LIPO N/A
  • SVRE N/A
  • Industry
  • LIPO Biotechnology: Pharmaceutical Preparations
  • SVRE
  • Sector
  • LIPO Health Care
  • SVRE
  • Exchange
  • LIPO Nasdaq
  • SVRE Nasdaq
  • Market Cap
  • LIPO 3.1M
  • SVRE 2.9M
  • IPO Year
  • LIPO 2022
  • SVRE 2022
  • Fundamental
  • Price
  • LIPO $2.53
  • SVRE $3.21
  • Analyst Decision
  • LIPO Strong Buy
  • SVRE
  • Analyst Count
  • LIPO 1
  • SVRE 0
  • Target Price
  • LIPO $16.00
  • SVRE N/A
  • AVG Volume (30 Days)
  • LIPO 45.5K
  • SVRE 11.5K
  • Earning Date
  • LIPO 05-08-2025
  • SVRE 03-21-2025
  • Dividend Yield
  • LIPO N/A
  • SVRE N/A
  • EPS Growth
  • LIPO N/A
  • SVRE N/A
  • EPS
  • LIPO N/A
  • SVRE N/A
  • Revenue
  • LIPO $536,357.00
  • SVRE $462,071.00
  • Revenue This Year
  • LIPO N/A
  • SVRE $597.62
  • Revenue Next Year
  • LIPO N/A
  • SVRE N/A
  • P/E Ratio
  • LIPO N/A
  • SVRE N/A
  • Revenue Growth
  • LIPO 19.29
  • SVRE N/A
  • 52 Week Low
  • LIPO $2.02
  • SVRE $0.30
  • 52 Week High
  • LIPO $12.00
  • SVRE $21.60
  • Technical
  • Relative Strength Index (RSI)
  • LIPO 46.60
  • SVRE 39.25
  • Support Level
  • LIPO $2.13
  • SVRE $2.96
  • Resistance Level
  • LIPO $2.74
  • SVRE $5.45
  • Average True Range (ATR)
  • LIPO 0.21
  • SVRE 0.30
  • MACD
  • LIPO 0.05
  • SVRE -0.31
  • Stochastic Oscillator
  • LIPO 67.61
  • SVRE 6.00

About LIPO Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.

About SVRE SaverOne 2014 Ltd.

Saverone 2014 Ltd provides driver protection solutions. The company develops and deploys ADAS technologies for transportation safety and driver assistance. The company's product restricts the driver from surfing, communicating, and receiving alerts while driving. The Company has developed a system that provides a solution to the problem of distracted driving caused by cell phone use, which endangers the driver, passengers, other drivers on the road, and pedestrians.

Share on Social Networks: